Reviva pharmaceuticals to participate in the benchmark company's upcoming discovery one-on-one investor conference

Cupertino, calif., nov. 30, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo, and narayan prabhu, cfo of reviva, will participate in the benchmark company's discovery one-on-one investor conference, taking place december 7, 2023 in new york, ny.
RVPH Ratings Summary
RVPH Quant Ranking